Seasonal Influenza Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2028

 

Influenza is a contagious respiratory disease caused by influenza viruses that can lead to hospitalization and, in severe cases, death. In humans, influenza virus infects the respiratory tract (nose, throat, and lungs). Seasonal influenza is detected all year, and the virus is most common during the influenza season, particularly in the fall and winter months. Furthermore, the exact timing and duration of the influenza season varies; however, influenza activity typically begins in the winter months. Influenza infection is present at a low level throughout the year in various geographical regions, but it shows a seasonal increase, typically during the winter months. A seasonal influenza flu vaccine helps to reduce the risk of becoming infected with seasonal flu and to keep it from spreading throughout the year.

The viral infection caused by flu in the respiratory system is known as influenza. The Seasonal Influenza Vaccines Market spreads through respiratory droplets and is highly contagious. It can also spread from one person to another through conversation or physical contact. The influenza virus circulates indefinitely, causing regional epidemics and outbreaks that kill thousands. The changing nature of the virus necessitates an annual change in the vaccine strain to match the influenza virus strain. Healthcare organisations around the world, such as the Centers for Disease Control and Prevention (CDC), have suggested vaccines such as baloxavir marboxil (Xofluza) for the treatment of influenza.

Seasonal Influenza Vaccines Market contain three different influenza viruses: influenza type A with H3N2 virus strain, influenza type A with H1N1 virus strain, and influenza type B virus strain. Increased prevalence of influenza epidemics and seasonal outbreaks are expected to boost product sales during the forecast period.

Key Players

Seasonal Influenza Vaccines Market contain three strains of influenza viruses: influenza type A with H3N2, influenza type A with H1N1, and influenza type B virus strain. During the forecast period, increased prevalence of influenza epidemics and seasonal outbreaks are expected to boost product sales.